SCHEMBL8480929

SCHEMBL8480929

CCCCc1c(N2CCCCC2)ccc2c1C(C(=O)NCCC)c1ccccc1-2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.44
▸ DRD4 P21917 3/20 0.44
▸ DRD3 P35462 3/20 0.44
▸ KMT2A Q03164 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ FKBP1A P62942 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8593680 0.89 POLB (0.42) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8675068 0.87 L3MBTL1 (0.42) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8485122 0.86 DRD2 (0.39) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8627056 0.85 POLB (0.39) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8480412 0.85 DRD2 (0.37) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8714745 0.84 CHRM1 (0.41) DRD2DRD4DRD3KMT2AHPGD
SCHEMBL8502239 0.84 DRD2 (0.39) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8503794 0.84 DRD2 (0.38) DRD2DRD4DRD3KMT2AMAPT
SCHEMBL8669688 0.83 DRD2 (0.39) DRD2DRD4DRD3NPSR1KDM4E
SCHEMBL8668074 0.83 DRD2 (0.37) DRD2DRD4DRD3KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
Send feedback